| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | +101.2% |
| Cost of Revenue | $7.3M | +81.4% |
| Gross Profit | $3.9M | +152.7% |
| R&D Expense | $203K | +123.6% |
| SG&A Expense | $23.9M | +282.3% |
| Operating Income | -$25.2M | -48.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$19.2M | +39.9% |
| Income Tax | -$36K | -171.3% |
| Net Income | -$19.2M | +40.0% |
| EPS (Basic) | -$0.74 | +80.7% |
| EPS (Diluted) | -$0.74 | +80.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.3M | +2648.3% |
| Short-term Investments | $39.2M | — |
| Accounts Receivable | $1.6M | +2250.3% |
| Inventory | $5.3M | +298.1% |
| Current Assets | $159.5M | +2516.8% |
| Total Assets | $182.7M | +1034.3% |
| Current Liabilities | $2.6M | +178.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | -429.9% |
| Capital Expenditures | $2.1M | — |
| Investing Cash Flow | -$37.1M | -4249.3% |
| Financing Cash Flow | $157.8M | +1945.8% |
| Free Cash Flow | -$23.2M | -481.5% |
| $7.8M |
| +502.4% |
| Stockholders' Equity | $174.9M | +1080.6% |